NOVARTIS AG-REG (1NOVN.MI) Forecast, Price Target & Analyst Ratings
BIT:1NOVN • CH0012005267
134 EUR
-7 (-4.96%)
Last: Mar 9, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVARTIS AG-REG (1NOVN.MI).
Forecast Snapshot
Consensus Price Target
€132.60
-1.04% Downside
Next Earnings Forecast
Release DateApr 27, 2026
PeriodQ1 / 2026
EPS Estimate$2.15
Revenue Estimate13.825B
ChartMill Buy Consensus
70.59%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€132.60
Upside
-1.04%
From current price of €134.00 to mean target of €132.60, Based on 34 analyst forecasts
Low
€98.33
Median
€133.34
High
€206.75
Price Target Revisions
1 Month
13.06%
3 Months
13.06%
Price Target Summary
34 Wall Street analysts provided a forecast for the next 12 months for 1NOVN.MI. The average price target is 132.6 EUR. This implies a price decrease of -1.04% is expected in the next year compared to the current price of 134.
The average price target has been revised upward by 13.06% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
70.59%
1NOVN.MI was analyzed by 34 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about 1NOVN.MI.
In the previous month the buy percentage consensus was at a similar level.
1NOVN.MI was analyzed by 34 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 27, 2026
PeriodQ1 / 2026
EPS Estimate$2.15
Revenue Estimate13.825B
Revenue Q2Q4.47%
EPS Q2Q-5.65%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
-1.24%
Revenue (3 Months)
-0.34%
EPS (1 Month)
-5.37%
EPS (3 Months)
-13.07%
Next Earnings Summary
1NOVN.MI is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is 2.15 EUR and the consensus revenue estimate is 13.82B EUR.
The next earnings revenue estimate has been revised downward by 0.34% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 46.66B 7.57% | 51.722B 10.85% | 56.33B 8.91% | 58.125B 3.19% | 60.978B 4.91% | 64.487B 5.75% | 69.701B 8.09% | 72.171B 3.54% | 70.192B -2.74% | 67.191B -4.28% | 64.861B -3.47% | |
| EBITDA YoY % growth | 20.919B 20.31% | 20.919B | 24.017B 14.81% | 23.786B -0.96% | 25.378B 6.69% | 27.583B 8.69% | 30.438B 10.35% | 32.201B 5.79% | 29.356B -8.84% | 27.435B -6.54% | 26.31B -4.10% | |
| EBIT YoY % growth | 12.642B 23.87% | 16.32B 29.09% | 18.692B 14.53% | 21.034B 12.53% | 22.513B 7.03% | 24.354B 8.18% | 28.023B 15.07% | 29.22B 4.27% | 29.497B 0.95% | 25.596B -13.23% | 24.334B -4.93% | |
| Operating Margin | 27.09% | 31.55% | 33.18% | 36.19% | 36.92% | 37.77% | 40.20% | 40.49% | 42.02% | 38.09% | 37.52% | |
| EPS YoY % growth | 6.90 12.75% | 7.81 13.19% | 8.98 14.98% | 9.04 0.69% | 9.86 9.05% | 10.68 8.35% | 12.23 14.48% | 12.88 5.30% | 12.52 -2.83% | 11.13 -11.08% | 10.64 -4.40% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 2.15 -5.65% | 2.30 -5.12% | 2.26 0.50% | 2.03 0.24% |
| Revenue Q2Q % growth | 13.825B 4.47% | 14.473B 2.98% | 14.452B 3.90% | 14.414B 8.08% |
| EBITDA Q2Q % growth | 4.868B -18.05% | 5.254B -30.55% | 5.692B -31.91% | 5.522B -41.82% |
| EBIT Q2Q % growth | 5.186B 8.36% | 5.413B 5.00% | 5.569B 21.46% | 5.091B 22.20% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
5.96%
EPS Next 5 Year
7.48%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.46%
Revenue Next 5 Year
4.99%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
9.08%
EBIT Next 5 Year
8.66%
NOVARTIS AG-REG / 1NOVN.MI Forecast FAQ
What is the average price target for NOVARTIS AG-REG (1NOVN.MI) stock?
34 analysts have analysed 1NOVN.MI and the average price target is 132.6 EUR. This implies a price decrease of -1.04% is expected in the next year compared to the current price of 134.
What is the next earnings date for 1NOVN stock?
NOVARTIS AG-REG (1NOVN.MI) will report earnings on 2026-04-27.
Can you provide the consensus estimates for NOVARTIS AG-REG next earnings?
The consensus EPS estimate for the next earnings of NOVARTIS AG-REG (1NOVN.MI) is 2.15 EUR and the consensus revenue estimate is 13.82B EUR.
What is the consensus rating for NOVARTIS AG-REG (1NOVN.MI) stock?
The consensus rating for NOVARTIS AG-REG (1NOVN.MI) is 70.5882 / 100 . This indicates that analysts generally have a positive outlook on the stock.